lenalidomide and POEMS Syndrome
lenalidomide has been researched along with POEMS Syndrome in 57 studies
Research
Studies (57)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (3.51) | 29.6817 |
2010's | 41 (71.93) | 24.3611 |
2020's | 14 (24.56) | 2.80 |
Authors
Authors | Studies |
---|---|
Cheng, YD; Guo, R; Jiang, ZX; Wan, DM; Wang, M; Zhang, JL | 1 |
Hountras, P; Lane, T | 1 |
Cheng, S; Fan, W; Ge, Y; Huang, L; Jiang, S; Liang, D; Zhu, X | 1 |
Aotsuka, Y; Kano, H; Kuwabara, S; Mimura, N; Misawa, S; Morooka, M; Nakamura, K; Ohwada, C; Otani, R; Sakaida, E; Sekiguchi, Y; Shibuya, K; Suichi, T; Takeda, Y; Tsukamoto, S | 1 |
Chiba, A; Honda, A; Ikemura, M; Kurokawa, M; Maki, H; Masamoto, Y; Oyama, T; Taoka, K | 1 |
Gong, D; Huang, W; Wang, Z; Yin, S; Zhou, K | 1 |
Hong, L; Huang, H; Lin, Z; Lu, J; Luo, L; Wang, C; Wang, X; Xu, R; Zhou, L | 1 |
Ikeda, S; Kameoka, Y; Kobayashi, T; Komatsuda, A; Saito, M; Takahashi, N; Ubukawa, K | 1 |
Agathokleous, A; Georgiou, S; Kyriakou, G; Marnellos, P; Solomou, EE; Symeonidis, A | 1 |
Amino, H; Iwai, Y; Katayama, K; Kuwabara, S; Misawa, S; Nagashima, K; Nakamura, K; Sato, Y; Sekiguchi, Y; Shibuya, K; Suichi, T; Suzuki, YI; Tsuneyama, A | 1 |
Arai, H; Handa, T; Ichikawa, M; Mitani, K; Nakamura, F; Nakamura, Y; Okazaki, A; Sasaki, K; Seo, S; Takahashi, W | 1 |
Dai, RP; Gao, XM; Li, J; Liu, LS; Zhang, X; Zhao, H; Zhou, DB | 1 |
Cao, X; Gao, X; Huang, X; Li, J; Xia, W; Yang, H; Zhao, H; Zhou, D | 1 |
Cai, H; Cai, QQ; Cao, XX; Gao, XM; Le, J; Li, J; Zhao, H | 1 |
Gao, Y; Li, J; Liu, Y; Wang, T; Yang, L; Zhang, S | 1 |
Khouri, J; Nakashima, M; Wong, S | 1 |
Abuomar, W; Al Sughaiyer, H; Al-Mayoof, O; Khan, M | 1 |
Collado-Borrell, R; Escudero-Vilaplana, V; González-Arias, E; Osorio-Prendes, S; Sanjurjo-Sáez, M | 1 |
Autore, F; Bacigalupo, A; Chiusolo, P; Innocenti, I; Laurenti, L; Luigetti, M; Piccirillo, N; Sica, S; Sora, F | 1 |
Akiyama, H; Hara, D; Hasegawa, Y; Hoshikawa, M; Nukui, S; Shimizu, T | 1 |
Adami, F; Briani, C; Gallia, F; Giordano, L; Merlini, G; Nobile-Orazio, E; Nozza, A; Santoro, A; Terenghi, F | 1 |
Boulard, C; Courville, P; Gremain, V; Langlois, V; Litrowski, N; Marguet, F; Zarnitsky, C | 1 |
Jaccard, A | 1 |
Hashida, H; Hatano, K; Irie, K; Matsumoto, H; Mitsutake, A; Tsukada, N | 1 |
Cai, H; Cai, QQ; Cao, XX; Gale, RP; Huang, XF; Li, J; Wang, C; Zhang, L; Zhao, H; Zhou, DB | 1 |
Khan, M; Stone, K; van Rhee, F | 1 |
Bianco, M; Fayoumi, MZ; Gallia, F; Giannotta, C; Nobile-Orazio, E; Nozza, A; Scarale, A; Terenghi, F | 1 |
Gilbert, L; Ordway, S; Wanko, S | 1 |
D'Sa, S; Keddie, S; Lunn, MP | 1 |
Cao, X; Huang, X; Li, J; Yang, H; Zhao, H; Zhou, D | 1 |
Bashir, Q; Champlin, RE; Delgado, R; Hosing, C; Kebriaei, P; Lee, HC; Manasanch, EE; Nieto, Y; Orlowski, RZ; Patel, KK; Patel, RD; Popat, U; Qazilbash, MH; Rondon, G; Saini, NY; Thomas, SK; Varma, A; Weber, DM | 1 |
Cai, H; Cao, XX; Feng, J; Gao, XM; Huang, XF; Li, J; Zhang, L; Zhao, H; Zhou, DB | 1 |
Chen, BY; Chen, WM; Liao, LS; Lin, Y; Qu, S; Wei, TN; Xie, Y; Zheng, ZH | 1 |
Kuwabara, S | 3 |
Fujita, C; Goto, A; Ibata, S; Ikeda, H; Iyama, S; Kato, J; Kikuchi, S; Kobune, M; Murase, K; Sugama, Y; Takada, K; Tatekoshi, A; Yoshida, M | 1 |
Anzai, T; Fukushima, A; Iwano, H; Matsuno, Y; Nakano, I; Naya, M; Oyama-Manabe, N; Shimizu, A; Takahashi, Y | 1 |
Boku, S; Hosoda, T; Kagoo, T; Kudo, M; Ohashi, K; Ueno, H; Yamamoto, R; Yano, T; Yokoyama, A; Yoneda, M | 1 |
Dimopoulos, MA; Gavriatopoulou, M; Kastritis, E; Psaltopoulou, T; Sergentanis, TN; Terpos, E; Zagouri, F | 1 |
Blin, N; Caristan, A; Connault, J; Duhamel, E; Graveleau, J; Hamidou, M; Le Gouill, S; Lestang, E; Maisonneuve, H; Masseau, A; Moreau, P; Néel, A; Touzeau, C | 1 |
Cai, H; Cai, QQ; Cao, XX; Li, J; Wang, C; Zhou, DB | 1 |
Campus, C; Ringuette, B; Robey, RC; Shumate, M | 1 |
Cai, QQ; Guan, YZ; Li, J; Su, W; Wang, C; Zhou, DB | 1 |
Cai, Q; Cao, X; Huang, X; Li, J; Wang, C; Yang, H; Zhou, D | 1 |
Cai, H; Cai, QQ; Cao, XX; Dai, RP; Huang, XF; Li, J; Zhang, X; Zhou, DB | 1 |
Arabi, H; Penumetcha, R; Sethi, S; Tageja, N | 1 |
Sucak, GT; Suyanı, E; Yağcı, M | 1 |
Giraldo, P; Lecumberri, R; Nistal, S; Tomás, JF | 1 |
Adami, F; Briani, C; Citton, V; Lessi, F; Manara, R; Zambello, R | 1 |
Fujita, Y; Furuta, N; Ikeda, M; Okamoto, K; Tashiro, Y | 1 |
Balducci, M; Chiusolo, P; De Stefano, V; Giannotta, C; Laurenti, L; Leone, G; Luigetti, M; Sabatelli, M; Sica, S; Sorà, F; Vannata, B | 1 |
Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Mayer, J; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L | 1 |
Fujisawa, S; Fujita, H; Imai, N; Ishigatsubo, Y; Matsuura, S; Ogusa, E; Taguchi, J; Tomita, N | 1 |
Abraham, J; Asli, B; Banos, A; Brisseau, JM; Choquet, S; Decaux, O; Deplanque, G; Facon, T; Fermand, JP; Galicier, L; Godmer, P; Guichard, I; Haroche, J; Hermine, O; Jaccard, A; Leblond, V; Leleu, X; Marolleau, JP; Merlusca, L; Musset, L; Recher, C; Roussel, M; Royer, B; Sebban, C | 1 |
Li, J; Zhou, DB | 1 |
Dispenzieri, A; Klein, CJ; Mauermann, ML | 1 |
Reviews
10 review(s) available for lenalidomide and POEMS Syndrome
Article | Year |
---|---|
Coexistence of primary mediastinal MALT lymphoma and multiple myeloma like POEMS syndrome: A case report and literature review.
Topics: Bortezomib; Humans; Lenalidomide; Lymphoma, B-Cell, Marginal Zone; Multiple Myeloma; POEMS Syndrome; Rituximab; Thymus Neoplasms | 2023 |
Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Topics: Humans; Lenalidomide; Monoclonal Gammopathy of Undetermined Significance; Paraproteinemias; POEMS Syndrome; Vascular Endothelial Growth Factor A | 2021 |
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
Topics: Angiogenesis Inhibitors; Biomarkers; Hematopoietic Stem Cell Mobilization; Humans; Lenalidomide; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Thalidomide; Transplantation, Autologous; Treatment Outcome; Vascular Endothelial Growth Factor A | 2018 |
POEMS Syndrome: Therapeutic Options.
Topics: Allografts; Humans; Lenalidomide; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Radiotherapy; Thalidomide | 2018 |
[Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Topics: Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Secondary Prevention; Thalidomide; Transplantation, Autologous; Treatment Outcome | 2013 |
Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Humans; Immunologic Factors; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide; Treatment Outcome | 2014 |
[Crow-Fukase (POEMS) syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Humans; Immunoglobulin lambda-Chains; Lenalidomide; Melphalan; Paraneoplastic Syndromes, Nervous System; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2010 |
[New treatment strategy for Crow-Fukase (POEMS) syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Combined Modality Therapy; Demyelinating Diseases; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2010 |
[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Topics: Aged; Castleman Disease; Erdheim-Chester Disease; Female; Histiocytosis, Langerhans-Cell; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Thalidomide | 2012 |
New advances in the diagnosis and treatment of POEMS syndrome.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2013 |
Trials
6 trial(s) available for lenalidomide and POEMS Syndrome
Article | Year |
---|---|
Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prospective Studies; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult | 2020 |
Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Anti-Inflammatory Agents; Biomarkers, Tumor; Dexamethasone; Female; Gene Expression; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prognosis; Prospective Studies; RNA, Messenger; Treatment Outcome; Ubiquitin-Protein Ligases; Up-Regulation; Young Adult | 2021 |
Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Topics: Adult; Aged; Biomarkers; Biopsy; Dexamethasone; Drug Therapy, Combination; Duration of Therapy; Female; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Skin; Symptom Assessment; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult | 2021 |
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
Topics: Adult; Aged; Angiogenesis Inhibitors; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lenalidomide; Male; Middle Aged; Pilot Projects; POEMS Syndrome; Prospective Studies; Survival Analysis; Thalidomide; Treatment Outcome | 2017 |
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Topics: Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Remission Induction; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult | 2018 |
Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.
Topics: Adult; Aged; Biomarkers; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prognosis; Symptom Assessment; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Time Factors; Treatment Outcome; Young Adult | 2019 |
Other Studies
41 other study(ies) available for lenalidomide and POEMS Syndrome
Article | Year |
---|---|
[The Clinical Characteristics and Outcomes of the Patients with POEMS Syndrome].
Topics: Aged; Aged, 80 and over; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Middle Aged; POEMS Syndrome; Retrospective Studies; Transplantation, Autologous | 2021 |
A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Edema; Exercise Tolerance; Humans; Hypertension, Pulmonary; Lenalidomide; Male; Neoplasms, Plasma Cell; Peripheral Nervous System Diseases; Phosphodiesterase 5 Inhibitors; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Stem Cell Transplantation; Syncope; Tadalafil; Weight Loss | 2022 |
Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
Topics: Adult; Dexamethasone; Endothelial Cells; Humans; Kidney Diseases; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide; Vascular Endothelial Growth Factor A | 2022 |
Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Topics: Boron Compounds; Dexamethasone; Endocrine System Diseases; Glycine; Humans; Lenalidomide; Monoclonal Gammopathy of Undetermined Significance; POEMS Syndrome; Vascular Endothelial Growth Factor A | 2022 |
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Topics: Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Plasmacytoma; POEMS Syndrome; Thalidomide; Transplantation, Autologous | 2023 |
POEMS syndrome: origination from clonal plasma cells or B cells?
Topics: Aged; B-Lymphocytes; Humans; Lenalidomide; Male; POEMS Syndrome; Remission Induction; Vascular Endothelial Growth Factor A | 2023 |
Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone.
Topics: Aged; Dexamethasone; Flow Cytometry; Glomerulonephritis; Hemangioma; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunologic Factors; Lenalidomide; Male; Paraproteinemias; Pigmentation Disorders; Plasma Cells; POEMS Syndrome; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2019 |
Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Dyspnea; Edema; Humans; Lenalidomide; Male; Muscle Weakness; Nails, Malformed; POEMS Syndrome; Skin; Smoldering Multiple Myeloma | 2019 |
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
Topics: Aged; Dexamethasone; Female; Humans; Lenalidomide; Plasmacytoma; POEMS Syndrome; Vascular Endothelial Growth Factor A | 2020 |
Reliability of optic disc edema area in estimating the severity of papilledema in patients with POEMS syndrome.
Topics: Humans; Lenalidomide; Papilledema; POEMS Syndrome; Prospective Studies; Reproducibility of Results | 2020 |
Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
Topics: Adrenal Insufficiency; Adult; Aged; Angiogenesis Inhibitors; Dexamethasone; Female; Humans; Hypogonadism; Hypothyroidism; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Young Adult | 2020 |
POEMS syndrome: a rare cause of exudative ascites and chronic peripheral neuropathy.
Topics: Adult; Ascites; Dexamethasone; Humans; Lenalidomide; Male; Myeloma Proteins; Paraproteinemias; Peripheral Nervous System Diseases; Plasmacytoma; POEMS Syndrome; Sacrum; Thalidomide | 2017 |
Eosinophilia secondary to lenalidomide therapy.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Cyclophosphamide; Dexamethasone; Eosinophilia; Female; Humans; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide | 2018 |
Utility of osteosclerotic lesion biopsy in diagnosis of POEMS syndrome: A case report.
Topics: Arthritis, Rheumatoid; Cell Proliferation; Diagnosis, Differential; Female; Humans; Immunoelectrophoresis; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Systemic; Middle Aged; Neurologic Examination; Osteosclerosis; Plasma Cells; POEMS Syndrome; Sjogren's Syndrome; Thalidomide; Treatment Outcome | 2017 |
Necrotizing autoimmune myopathy associated with POEMS syndrome report.
Topics: Autoimmune Diseases; Dexamethasone; Electromyography; Humans; Lenalidomide; Male; Middle Aged; Muscular Diseases; POEMS Syndrome; Thalidomide | 2018 |
Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Topics: Adult; Brain; Brain Infarction; Dexamethasone; Female; Humans; Immunologic Factors; Ischemic Attack, Transient; Lenalidomide; Oligopeptides; POEMS Syndrome; Thalidomide | 2018 |
Daratumumab for POEMS Syndrome.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Lenalidomide; Middle Aged; POEMS Syndrome | 2018 |
Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome.
Topics: Action Potentials; Adult; Aged; Female; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Neural Conduction; POEMS Syndrome; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Vascular Endothelial Growth Factor A | 2019 |
POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
Topics: Adult; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Fatigue; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Polyneuropathies; Prednisone; Thalidomide | 2018 |
Advances in POEMS treatment and the need to define standardised outcome measures.
Topics: Biomarkers; Humans; Lenalidomide; Melphalan; Outcome Assessment, Health Care; POEMS Syndrome; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A | 2019 |
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasma Cells; Plasmapheresis; POEMS Syndrome; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 2019 |
What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Melphalan; Middle Aged; POEMS Syndrome; Remission Induction; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2019 |
[Autologous peripheral blood stem cell transplantation for POEMS syndrome].
Topics: Antineoplastic Agents, Alkylating; Biomarkers; Cyclophosphamide; Dexamethasone; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vascular Endothelial Growth Factor A | 2019 |
[Skin Changes in POEMS Syndrome].
Topics: Humans; Lenalidomide; POEMS Syndrome; Skin; Thalidomide; Vascular Endothelial Growth Factor A | 2019 |
[Treatment of POEMS syndrome with lenalidomide and dexamethasone].
Topics: Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; POEMS Syndrome; Randomized Controlled Trials as Topic; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2019 |
POEMS Syndrome Showing Left Ventricular Dysfunction and Extracellular Edema Assessed by Cardiac Magnetic Resonance Imaging.
Topics: Cytokines; Dexamethasone; Drug Therapy, Combination; Edema; Female; Glucocorticoids; Humans; Lenalidomide; Magnetic Resonance Imaging; Middle Aged; POEMS Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Dysfunction, Left | 2019 |
Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
Topics: Aged; Angiogenesis Inhibitors; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Recurrence; Remission Induction; Retrospective Studies; Thalidomide; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |
Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Recurrence; Thalidomide; Treatment Outcome | 2015 |
POEMS syndrome: complex factors contributing to a delayed diagnosis.
Topics: Delayed Diagnosis; Dexamethasone; Diagnosis, Differential; Electromyography; Glucocorticoids; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Neural Conduction; POEMS Syndrome; Thalidomide | 2015 |
Rapidly Progressive Polyneuropathy in a Patient With Monoclonal Gammopathy: A Case Report of POEMS Syndrome and Beyond.
Topics: Adult; Diagnosis, Differential; Disease Progression; Genetic Markers; Genetic Testing; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lenalidomide; Male; POEMS Syndrome; Thalidomide | 2016 |
Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
Topics: Adult; Aged; Dexamethasone; Female; Humans; Hypogonadism; Immunologic Factors; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prospective Studies; Sexual Dysfunction, Physiological; Thalidomide; Young Adult | 2016 |
OCULAR MANIFESTATIONS AND TREATMENT OUTCOMES IN CHINESE PATIENTS WITH POEMS SYNDROME.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Dexamethasone; Female; Humans; Lenalidomide; Male; Middle Aged; Papilledema; POEMS Syndrome; Prospective Studies; Thalidomide; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Young Adult | 2017 |
Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction.
Topics: Antineoplastic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide | 2009 |
Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Glucocorticoids; Hand Deformities, Acquired; Humans; Lenalidomide; POEMS Syndrome; Prednisolone; Proteasome Inhibitors; Remission Induction; Thalidomide; Vascular Endothelial Growth Factors | 2011 |
POEMS syndrome with severe neurological damage clinically recovered with lenalidomide.
Topics: Adult; Aged; Female; Humans; Lenalidomide; Male; Middle Aged; Nervous System Diseases; POEMS Syndrome; Recovery of Function; Thalidomide; Treatment Outcome | 2012 |
Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Topics: Aged; Castleman Disease; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Osteolysis; POEMS Syndrome; Prospective Studies; Thalidomide; Vascular Endothelial Growth Factor A | 2012 |
[A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].
Topics: Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Thalidomide; Waldenstrom Macroglobulinemia | 2012 |
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Humans; Humerus; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Prednisolone; Recurrence; Salvage Therapy; Thalidomide; Transplantation, Autologous | 2012 |
[POEMS syndrome treated with lenalidomide plus high-dose dexamethasone as a pre-transplant induction therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Neoadjuvant Therapy; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Thalidomide | 2012 |
Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Positron-Emission Tomography; Radiography; Recurrence; Retrospective Studies; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Lenalidomide therapy in a patient with POEMS syndrome.
Topics: Adult; Antineoplastic Agents; Black or African American; Diagnosis, Differential; Humans; Interleukin-6; Lenalidomide; Male; POEMS Syndrome; Thalidomide; Time Factors; Vascular Endothelial Growth Factor A | 2007 |